MAGCONTINE-2.6 TAB

Magcontine-2.6 Tablets contain Nitroglycerin 2.6 mg in a controlled-release formulation. It is a nitrate medicine used under medical supervision for the prevention and management of angina (chest pain) associated with coronary artery disease.

Magcontine-2.6 Tablets contain controlled-release Nitroglycerin 2.6 mg, a nitrate medicine that helps relax and widen blood vessels. This reduces the workload on the heart and improves blood flow to the heart muscle, helping prevent episodes of angina.

Key Features

  • Contains Nitroglycerin 2.6 mg.
  • Controlled-release formulation for prolonged therapeutic action.
  • Helps relax and widen blood vessels.
  • Reduces the workload and oxygen demand of the heart.
  • Used for the prevention and management of angina under medical supervision.

Composition

Each controlled-release tablet contains:

  • Nitroglycerin – 2.6 mg
  • Excipients – q.s.

Indication

Magcontine-2.6 Tablets are indicated for the prevention and management of angina pectoris (chest pain) due to coronary artery disease, as prescribed by a qualified healthcare professional.

Scroll to Top